Peptide marketing: build AI visibility on evidence

For a peptide-related business, “publish for AI search” is an incomplete marketing plan. Before choosing a channel, establish which product you are discussing, what the evidence supports and which claims the business can make.

A citation can extend the reach of an accurate explanation. It can also amplify a misleading one. This US-focused guide covers content planning, not treatment decisions or authorization of an individual campaign.

Identify the product before writing the claim

“Peptide” is not one regulatory category. An approved drug, an off-label use of an approved drug, a compounded preparation and an investigational product need different explanations.

FDA explains that it has not determined safety and effectiveness for an unapproved use of an approved drug. That is different from an unapproved product. FDA on off-label use.

Compounded drugs are not FDA-approved; FDA does not verify their safety, effectiveness or quality before marketing. Do not describe a compounded preparation as an approved generic. FDA compounding questions and answers.

For each offering, maintain the exact product and formulation, proposed use, primary source, review date and reviewed wording. Have the responsible clinical and regulatory reviewers establish the product-specific position before publishing.

Check paid-ad eligibility separately

Google Ads prohibits specified unapproved substances and products. Its rules do not support a blanket statement that every peptide campaign will fail or every clinic is eligible. Review the product, claim, destination and applicable market against current policy. Google Ads policy.

Organic distribution does not remove the need for substantiation. FTC health-products guidance generally expects reliable human clinical evidence appropriate to health-benefit claims. The evidence must fit the product, population and outcome being promised. FTC Health Products Compliance Guidance.

This is why an educational page should not be used to disguise a promotional claim rejected elsewhere. Fix the claim and evidence first.

Make a claim ledger

List proposed promises before building the content calendar. For each, record the product, audience, outcome, evidence, limitations, proposed wording and reviewer. Include implications from testimonials and imagery as well as explicit sentences.

Proposed sentence	Evidence to inspect	Editorial task
“Clinically proven to accelerate recovery”	Appropriate human evidence for the exact product and outcome	Hold or remove unless the reviewer establishes support
“A study examined this mechanism”	Original study, model and measured result	Explain the finding without implying a patient benefit
“The consultation includes an eligibility review”	Current clinic procedure	Describe the process without promising eligibility

These are editorial examples, not approved advertising copy. An animal finding does not establish a clinical benefit in people. A testimonial cannot supply missing evidence. Review the whole page's impression, not just the disclaimer. FTC guidance on substantiation and overall impression.

Publish explanations a reader can check

Begin with a small set of pages that answer different questions:

• Product status: which exact product is being discussed, and where can the reader verify its status?
• Evidence: what population, intervention, comparator and outcome did the research examine? What remains uncertain?
• Service process: who conducts the consultation, what does it include, where is it available and what do fees cover?
• Limitations: which questions require an individual assessment, and what can the service not promise?

Link the underlying sources beside the claims and date reviews where freshness matters. If research concerns a different formulation, say so next to the finding. Keep the medical decision with the qualified clinician.

These pages have a job even without AI citations: helping a reader understand the offering and ask informed questions. Use the customer-question workflow to give each page an evidence owner.

Evaluate the cost before expanding

AI visibility requires research, expert review, writing, measurement and maintenance. It is not automatically cheaper than paid acquisition.

For a fictional service with a $6,000 content pilot and $300 contribution per additional completed customer, break-even is 20 incremental customers. Ten contribute $3,000, leaving the pilot $3,000 short; thirty contribute $9,000, leaving $3,000 after pilot cost. These are decision-model inputs, not clinic benchmarks.

Use contribution after relevant variable costs, rather than total revenue. Track identifiable referrals, enquiry suitability and completed outcomes. Do not assume every referred customer is incremental, and keep patient-sensitive information out of general marketing reports.

Expand when the information is accurate, helps readers and has evidence of commercial value. Use the measurement guide to keep citations, visits and outcomes separate.

Sources checked October 4, 2026. Product status and promotional rules require a current, product-specific review before a campaign launches.